Journal Club 2017

 PDF-Link for institution's members only (password required, see infoboard of UVCM, Inselspital) 

  • Murakami K et al: Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut. 2016 Sep;65(9):1439-46. DOI-Link - PDF for institution members
  • Greuter T et al: Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept. Am J Gastroenterol. 2017 Jul 18. DOI-Link - PDF for institution members

  • Ang D et al: Diagnostic yield of high-resolution manometry with a solid test meal for clinically relevant, symptomatic oesophageal motility disorders: serial diagnostic study. Lancet Gastroenterol Hepatol. 2017 Jul 3. pii: S2468-1253(17)30148-6. DOI-Link - PDF for institution members
  • Camilleri M et al: Efficacy and Safety of Relamorelin in Diabetics with Symptoms of Gastroparesis:A Randomized, Placebo-Controlled Study. Gastroenterology. 2017 Jul 28. pii: S0016-5085(17)35966-8. DOI-Link - PDF for institution members

  • Kalla R et al: Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. Am J Gastroenterol. 2016 Dec;111(12):1796-1805. DOI-Link - PDF for institution members
  • Vanclooster A et al: Proton pump inhibitors decrease phlebotomy need in HFE hemochromatosis: double-blind randomized placebo-controlled trial. Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35740-2. DOI-Link - PDF for institution members

  • Jensen DM et al: Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage. Gastroenterology. 2017 May;152(6):1310-1318.e1. DOI-Link - PDF for institution members
  • Parséus A et al: Microbiota-induced obesity requires farnesoid X receptor. Gut. 2017 Mar;66(3):429-437. DOI-Link - PDF for institution members

  • Sandborn WJ et al: Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2017 May 4;376(18):1723-1736. DOI-Link - PDF for institution members

  • Inamdar S et al: Weekend vs. Weekday Admissions for Cholangitis Requiring an ERCP: Comparison of Outcomes in a National Cohort. Am J Gastroenterol. 2016 Mar;111(3):405-10. DOI-Link - PDF for institution members
  • Mayerle J et al: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut. 2017 Jan 20. pii: gutjnl-2016-312432. DOI-Link - PDF for institution members

  • Reig M et al: Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol. 2016 Oct;65(4):719-26. DOI-Link - PDF for institution members

  • Sinha R et al: Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. J Hepatol.  2017 Feb 16 pii: S0168-8278(17)30073-9. DOI-Link - PDF for institution members

  • Shen NT et al: Timely use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: a Systematic Review with Meta-Regression Analysis. AGastroenterology. 2017 Feb 9. pii: S0016-5085(17)30136-1. DOI-Link - PDF for institution members
  • Masamune A et al: Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017 Mar;66(3):487-494. DOI-Link - PDF for institution members

  • Casanova MJ et al: Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. Am J Gastroenterol. 2017 Jan;112(1):120-131. DOI-Link - PDF for institution members
  • Wernli KJ et al: Risks Associated With Anesthesia Services During Colonoscopy. Gastroenterology. 2016 Apr;150(4):888-94; quiz e18. DOI-Link - PDF for institution members

  • Liou JM et al: Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet Glob Health. 2016 Dec;4(12):e966-e977. DOI-Link - PDF folgt
  • Greenland K et al:Multiple behaviour change intervention for diarrhoea control in Lusaka, Zambia: a cluster randomised trial. Lancet. 2016 Nov 12;388(10058):2355-2365. DOI-Link - PDF folg

  • Scarpignato C et al: Rifaximin Reduces Number and Severity of Intestinal Lesions Associated With use of Non-steroidal Anti-inflammatory Drugs in Humans. Gastroenterology. 2016 Dec 19. pii: S0016-5085(16)35504-4. DOI-Link - PDF folgt

© 2012-2015 Gastroenterology & Mucosal Immunology, Bern, Switzerland
Swiss Web Design